NIA Clinical Research Unit
Baltimore, Maryland, 21225, United States
NCT Number: NCT00744120
This follow-up protocol is designed to evaluate participants who have previously been lymphoma patients treated on approved clinical studies of the National Institutes of Health.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Baltimore, Maryland, 21225, United States
The intent of this protocol is to accrue up to 800 volunteers who are interested in participating in NIA research studies as part of follow-up for previous cancer treatment at NIH. Participants will be asked to answer questions regarding their general health status, diagnoses, and admissions to hospital, and to provide possible documentation. They may be asked to come to the NIA Clinical Research Unit at Harbor Hospital to participate in a follow-up evaluation. They will have the opportunity to obtain additional information about studies in which they may wish to participate and to discuss eligibility issues with NIA staff members. Any identified clinical problems in need of care will also be discussed. Volunteers may be referred, with their permission, to their private medical doctor for follow-up. They may be re-evaluated within a year for further follow-up.
The follow-up evaluation may include history and physical, blood and urine tests, questionnaire, MRI or CT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Annually
Time frame: Annually
National Institute on Aging (NIA)
Nih
Lymphoma Follow-up Protocol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01695005
Hemic and Lymphatic Diseases, Immune System Diseases
Miami, Florida, United States
View Trial DetailsNCT06389357
ALL, Childhood, AML, Childhood
Ankara, Cankaya, Turkey (Türkiye)
View Trial DetailsNCT06582849
Adnexal Diseases, Anal Cancer
St Louis, Missouri, United States
View Trial DetailsNCT04169321
Hemic and Lymphatic Diseases, Immune System Diseases
Birmingham, Alabama, United States
View Trial Details